|
KIAA0907 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.87578857896642E-13 |
| Normal-vs-Stage2 |
3.50039999985619E-07 |
| Normal-vs-Stage3 |
3.35469996226578E-09 |
| Normal-vs-Stage4 |
4.30140000284851E-08 |
| Stage1-vs-Stage2 |
8.498100E-02 |
| Stage1-vs-Stage3 |
1.717240E-01 |
| Stage1-vs-Stage4 |
6.299600E-02 |
| Stage2-vs-Stage3 |
6.928600E-01 |
| Stage2-vs-Stage4 |
8.560400E-01 |
| Stage3-vs-Stage4 |
5.268400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.85890000562006E-09 |
| Normal-vs-Asian |
5.022600E-04 |
| Caucasian-vs-AfricanAmerican |
3.963600E-02 |
| Caucasian-vs-Asian |
1.697830E-02 |
| AfricanAmerican-vs-Asian |
9.784300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.2854608750531E-14 |
| Male-vs-Female |
8.049800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.037800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.6242562850266E-12 |
| Normal-vs-Age(61-80Yrs) |
2.84183787613301E-12 |
| Normal-vs-Age(81-100Yrs) |
3.882100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.657350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.100200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.723400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.212400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.996400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.785400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.182140E-03 |
| Normal-vs-Grade 2 |
7.4718009557273E-14 |
| Normal-vs-Grade 3 |
8.21565038222616E-14 |
| Normal-vs-Grade 4 |
1.60478999999825E-05 |
| Grade 1-vs-Grade 2 |
1.424780E-01 |
| Grade 1-vs-Grade 3 |
2.797000E-01 |
| Grade 1-vs-Grade 4 |
1.777560E-01 |
| Grade 2-vs-Grade 3 |
4.637600E-01 |
| Grade 2-vs-Grade 4 |
9.214200E-01 |
| Grade 3-vs-Grade 4 |
5.542800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.44089209850063E-15 |
| Normal-vs-ccB subtype |
3.91950000233621E-08 |
| ccA subtype-vs-ccB subtype |
1.339210E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63502544836547E-12 |
| Normal-vs-N1 |
1.273530E-02 |
| N0-vs-N1 |
8.540800E-01 |
|
|
